Literature DB >> 26991711

A Cross-Sectional Study of Patients' Satisfaction With Totally Implanted Access Ports.

Christoph Minichsdorfer1, Thorsten Füreder1, Bruno Mähr1, Anna S Berghoff1, Helga Heynar1, Anne Dressler1, Michael Gnant1, Christoph Zielinski1, Rupert Bartsch1.   

Abstract

BACKGROUND: Totally implanted access ports (PACs) are valuable tools for the treatment of patients with cancer because they ease the administration of chemotherapy, stem cells, and supportive care by reducing the rate of peripheral vein punctures.
OBJECTIVES: The purpose of this study was to evaluate the satisfaction and impairments of activities of daily living of ambulatory patients with PAC systems receiving chemotherapy.
METHODS: This cross-sectional, questionnaire-based study evaluated 202 patients with PAC systems in a comprehensive cancer center and cancer rehabilitation center. From November 2012 to August 2013, patients were invited to answer a questionnaire concerning quality of life and satisfaction with their PAC devices. Data regarding PAC-related complications were collected retrospectively by searching patients' medical history.
FINDINGS: A total of 202 patients with 230 PAC devices were included. Median time from PAC implantation to inclusion in the study was nine months. Surgical complications occurred in some cases, with bleeding and hematoma being the most frequently observed events. Late complications consisted of infections, drug extravasation, PAC malposition, PAC malfunction, and thrombosis. A third of the patients reported that their PAC interfered with activities of daily living. However, most agreed that PAC systems alleviated the burden of chemotherapy administration, and the vast majority said they would choose the implantation of a PAC system for chemotherapy administration again.

Entities:  

Keywords:  catheter-associated infection; quality of life; totally implanted access ports

Mesh:

Year:  2016        PMID: 26991711     DOI: 10.1188/16.CJON.175-180

Source DB:  PubMed          Journal:  Clin J Oncol Nurs        ISSN: 1092-1095            Impact factor:   1.027


  6 in total

1.  Surgeon, not technique, defines outcomes after central venous port insertion.

Authors:  Audrey E Ertel; Zachary D McHenry; Vijay K Venkatesan; Dennis J Hanseman; Koffi Wima; Richard S Hoehn; Shimul A Shah; Daniel E Abbott
Journal:  J Surg Res       Date:  2016-11-04       Impact factor: 2.192

2.  Application of intracavitary ECG for positioning the totally implantable venous access port in the upper arm of cancer patients.

Authors:  Lihua Shi; Huihui Chen; Yaping Yang; Huifen Li; Jianfang Zhang
Journal:  Exp Ther Med       Date:  2022-06-01       Impact factor: 2.751

3.  Cephalic vein approach for the implantable central venous access: A retrospective review of the single institution's experiences; Cohort Study.

Authors:  Jiyoung Rhu; Kang Woong Jun; Byung Joo Song; Kiyoung Sung; Jinbeom Cho
Journal:  Medicine (Baltimore)       Date:  2019-11       Impact factor: 1.817

4.  A multicenter survey of patients' favorite type of nursing care and associated factors in Hebei Province, China.

Authors:  Hongzhi Lv; Yi Cui; Chao Li; Xiaoli Yan; Na Yang; Yadong Wang; Yingze Zhang
Journal:  PLoS One       Date:  2022-03-09       Impact factor: 3.240

5.  Comparison between ultrasound-guided TIVAD via the right innominate vein and the right internal jugular vein approach.

Authors:  Xingwei Sun; Xuming Bai; Jiaofeng Shen; Ziyang Yu; Zhixiang Zhuang; Yong Jin
Journal:  BMC Surg       Date:  2019-12-11       Impact factor: 2.102

6.  Outcomes following port-a-catheter placement in the Medicare population.

Authors:  Syed I Khalid; Samantha Maasarani; Rachyl M Shanker; Aaron Lee Wiegmann; Rita Wu; Nicholas J Skertich; Samantha L Terranella; Laura DeCesare; Edie Y Chan
Journal:  Surg Open Sci       Date:  2020-11-11
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.